Daily Roundup

RUL.ASX ENL.ASX IMU.ASX WRK.ASX CWY.ASX

RPMGlobal Delivers Strong Software Sales Growth in FY2025

RPMGlobal Holdings Limited (ASX: RUL) has reported impressive results for its software business in the 2025 financial year. The company saw a 30.9% increase in total contracted value (TCV) of software sales, reaching $100.8 million. Subscription license sales were up 33.6% to $100.7 million, reflecting RPMGlobal's focus on building a stable, recurring revenue base.

The company's pre-contracted, non-cancellable software revenue backlog also grew significantly, rising 24.2% to $200 million. This provides excellent visibility on future revenue streams. However, RPMGlobal will not be providing updates on its expected Group Revenue, Operating EBITDA, and Profit Before Tax, as these will include a part-year contribution from the recently divested Advisory division.

Enlitic Secures Funding for GE HealthCare Collaboration

Enlitic, Inc. (ASX: ENL) has completed the financial requirements for its strategic collaboration with GE HealthCare. The company raised A$10 million in capital and received an initial US$2 million advance payment from GE HealthCare.

Under the agreement, Enlitic's Laitek subsidiary will deliver between US$3-6 million per year (approximately A$4.6-9.2 million) of annual migration capacity to GE HealthCare over the next 5 years, representing a potential revenue opportunity of up to A$46 million. Enlitic is now focused on executing this promise, supporting healthcare providers in their transition to cloud infrastructure.

Imugene Receives A$5.8 Million R&D Tax Refund

Imugene Limited, a clinical-stage immuno-oncology company, has received a A$5.8 million research and development (R&D) tax refund for the 2024 financial year. This refund, which includes interest, will enable the further clinical development of Imugene's promising immuno-oncology pipeline.

Imugene's pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug, multiple immunotherapy B-cell vaccine candidates, and an oncolytic virotherapy. The company is well-funded and resourced to deliver on its commercial and clinical milestones.

Wrkr Extends Partnership with MUFG for AustralianSuper Services

Wrkr Ltd (ASX: WRK) has extended its strategic partnership with MUFG Retirement Solutions to deliver a comprehensive digital platform for AustralianSuper's Clearing House, Gateway, and Digital Employer Services. This initiative aligns with upcoming Payday Super reforms and aims to improve efficiency and compliance in superannuation administration.

The partnership will set a new benchmark in digital employer services, equipping AustralianSuper with a robust, future-ready platform that enhances operational efficiency and delivers an improved experience for both members and employers. Wrkr anticipates that this partnership extension will align with its Average Revenue per User (ARPU) targets once users are fully onboarded.

Cleanaway Acquires Contract Resources, Receives ACCC Approval

Cleanaway Waste Management Limited (ASX: CWY) has received ACCC approval to acquire Contract Resources, a leading provider of integrated technical services. The acquisition is expected to complete on 31 July 2025.

The acquisition will enhance Cleanaway's position in the industrial services and hazardous waste management sectors. It is expected to accelerate Cleanaway's strategy to capture the decommissioning, decontamination, and remediation (DD&R) opportunity, leveraging Contract Resources' market-leading reputation, technical capabilities, and Tier 1 oil & gas customer base.